Abstract

Aim. Analysis of influence of risk factors (RF) on progression of atherosclerosis of brachiocephalic arteries after unilateral carotid endarterectomy (CEA) with the underlying treatment with statins.
 Materials and Methods. 262 Cases (262 patients) were analyzed. Influence of RFs on the frequency of cerebral circulation disorders (CCD), myocardial infarction (MI), survival rate, condition of the carotid arteries and on lipid profile with the underlying treatment with statins was evaluated. In the early period the results were evaluated in 100% of patients, in a long-term period – in 93.5%. Patients were arranged in groups: a group that received simvastatin – 41.6% in the preoperative period and 24.5% in the long-term period, a group of atorvastatin – 51.9% and 54.7%, a group of rosuvastatin – 6.5% and 20.8%, respectively. Predominating (83.2%) were patients with more than 3 RFs (according to SCORE scale).
 Results. Lethality rate in the analyzed sample group was 6.5%, the rate of fatal cardio-vascular complications (CVC) – 7 cases (2.3%), of non-fatal CCD – 5 cases (1.9%). A significant influence on the progression of alterations in the carotid artery was found in patients with 3 RFs (p=0.03). The length of atherosclerotic plaque (ASP) was maximal in patients with 5 RFs (0.01). In the presence of more than 3 RFs, elevation of the total cholesterol (CL) and of low density lipoproteins (LDLP) was noted, p=0.001. In the long-term period in the atorvastatin group the level of LDLP decreased by 19%, p=0.0001, in the rosuvastatin group the level of HDLP increased by 3.4%, p=0.02. In the rosuvastatin group, the recommended values of CL were achieved 64.7% more often in comparison with the simvastatin group, p=0.03. The rate of CVC increased in patients >68 years of age, р=0.04. The lethality rate increased in case of body mass index (BMI) ≥25-30 kg/m2 (р=0.05) and in case of type 2 diabetes mellitus (p=0.03). The influence of the following factors on long-term results was demonstrated: smoking (p=0.04), arterial hypertension (p=0.019), chronic cardiac insufficiency (p=0.01), a tendency to bradycardia (p=0.03), atherosclerotic lesions of more than one arterial pool (p=0.006). RFs influenced the rate of development of restenosis of the internal carotid artery (ICA) >50% on the side of the operation in 4 observations (1.5%). In the atorvastatin group the most significant positive influence on lipid spectrum was observed in comparison with other groups (by 47.1%, р=0.001).Therapy with atorvastatin stabilized the wall of ICA and of the contralateral common carotid artery (CCA) 17.6% (p=0.05) more frequently in comparison with simvastatin and rosuvastatin.
 Conclusion. A direct influence of RFs on the progression of atherosclerotic alterations in the carotid arteries and on the rate of development of cardiovascular complications in the perioperative and long-term periods, and also influence of underlying statin therapy on the parameters of lipid metabolism, and a higher effectiveness of synthetic statins were determined.

Highlights

  • A significant influence on the progression of alterations in the carotid artery was found in patients with 3 risk factors (RF) (p=0.03)

  • In the long-term period in the atorvastatin group the level of low density lipoproteins (LDLP) decreased by 19%, p=0.0001, in the rosuvastatin group the level of HDLP increased by 3.4%, p=0.02

  • In the atorvastatin group the most significant positive influence on lipid spectrum was observed in comparison with other groups.Therapy with atorvastatin stabilized the wall of internal carotid artery (ICA) and of the contralateral common carotid artery (CCA) 17.6% (p=0.05) more frequently in comparison with simvastatin and rosuvastatin

Read more

Summary

ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ ORIGINAL STUDY

Оценивалось влияние ФР на фоне статинотерапии на частоту нарушений мозгового кровообращения (НМК), инфаркта миокарда (ИМ), выживаемость, состояние сонных артерий и липидного профиля. В раннем периоде оценены результаты у 100% пациентов, в отдаленном – у 93,5%. Пациенты распределены: группа симвастатина – 41,6% в периоперационном периоде и 24,5% – в отдаленном, аторвастатина – 51,9% и 54,7%, розувастатина – 6,5% и 20,8% соответственно. Значимое влияние на прогрессирование изменений в сонной артерии определялось у больных с 3 ФР (р=0,03). В отдаленном периоде в группе аторвастатина уровень ЛПНП снижался на 19,1%, р=0,0001, в группе розувастатина увеличивался уровень ЛПВП на 3,4%, р=0,02. Определена прямая взаимосвязь влияния ФР на прогрессирование атеросклеротических изменений в сонных артериях и частоту развития сердечно-сосудистых осложнений на протяжении периоперационного и отдаленного периодов, а также влияние проводимой статинотерапии на показатели липидного обмена и более высокая эффективность синтетических статинов.

WITH UNDERLYING TREATMENT WITH STATINS
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ
Факторы риска
Ранние послеоперационные осложнения
Findings
Влияние ФР на развитие ССО в отдаленном периоде
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.